Peptide library / Digestive & weight / 5-Amino-1MQ
5-Amino-1MQ
A small molecule, not a peptide, sold alongside peptides for fat loss.
Effects studied or claimed
What it is used or promoted for, and where each effect has actually been seen
- Fat loss in obese miceAnimals
How it is thought to work
5-Amino-1MQ blocks the enzyme NNMT in fat cells, which in mice raised cellular energy use and reduced fat.
What the evidence shows
Evidence comes from mouse studies. There are no human trials.
Safety and unknowns
Human safety is unknown.
Regulatory status
Not approved. Sold as a research chemical.
Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.
More in Digestive & weight
Albiglutide
FDA-approvedA weekly GLP-1 receptor agonist that proved heart benefit but was withdrawn for business reasons.
Amycretin
In clinical trialsAn investigational single molecule from Novo Nordisk that activates both GLP-1 and amylin receptors.
Tirzepatide
FDA-approvedA once-weekly dual GIP and GLP-1 receptor agonist approved for type 2 diabetes, obesity and sleep apnea in obesity.
General information, not medical advice. Do not buy or inject unregulated peptides.